项目委员会
-
Christer Backman, LLM International Coordinator & Senior Expert
Medical Products Agency, Sweden -
Gesine Bejeuhr, PHARMD Pediatric Regulatory Leader
Bayer AG, Germany -
Representative Invited European Federation of Pharmaceutical Industries and Associations (EFPIA) -
Gonzalo Calvo Rojas, PHD Consultant in Clinical Pharmacology
Hospital Clinic Barcelona, Spain -
Judith Creba, PHD Sr. Global Program Regulatory Director, Reg Affairs GDD Region EU
Novartis Pharma AG, Switzerland -
Luca De Nigro, MS Drugs Monitoring Register
Italian Medicines Agency (AIFA), Italy -
Vicki Edwards, RPH Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Shayesteh Fürst-Ladani, MBA, MS CEO
SFL Regulatory Affairs & Scientific Communication, Switzerland -
Christine Gispen De Wied, DrMed Scientific Programmanager
Medicines Evaluation Board, Netherlands -
Susanne Keitel, DRSC, RPH Director
European Directorate for the Quality of Medicines & Healthcare (EDQM), France -
John Kerridge, PHD, RPH Director Of Quality, External Manufacturing Europe, Africa, Asia
LILLY FRANCE, France -
Andrei Kravchenko, MD, PHD Head of Representative Office in Ukraine
SynteractHCR, Ukraine -
Jürgen Kübler, PHD Owner
Quantitative Scientific Consulting, Germany -
Hubert Leufkens, PHARMD, PHD Emeritus Professor of Pharmaceutical Policy and Regulatory Science
Utrecht University, Netherlands -
Hans H Linden, MS Executive Director
EUFEPS, Sweden -
Marta Marcelino
Infarmed, Portugal -
Robert Middel, MHS Head of External Alliances, Portfolio Delivery Operations
Janssen Biologics B.V., Netherlands -
Melek Onol Head of RA
Boehringer Ingelheim, Turkey -
Markus Georg Pasterk, MS COO and Vice President Science
IPRI, France -
Jan Petracek, MD, MSC CEO
iVigee Services a.s., Czech Republic -
Lidia Retkowska-Mika, LLM Director Legal DPT
Office For Registration of Med. Products, Medical Devices and Biocides, Poland -
Isabelle Stoeckert, PHARMD, PMP Independent Regulatory Science Expert
Independent, Germany -
Burkhard Straeter Lawyer
Sträter Rechtsanwälte, Germany -
Steven Teerenstra, PHD, MSC Statistician
Medicines Evaluation Board, Netherlands -
Sinisa Tomic, PHD Head of Agency
Croatian Agency for Medicinal Products and Medical Devices, Croatia -
Hans van Bruggen, MSC Director of Regulatory Affairs
Celegence, United States -
Jan Willem van der Laan, PHD Senior Assessor Pharmacology and Toxicology
Retired From Medicines Evaluation Board, Netherlands -
Nermeen Y. Varawalla Executive Vice President, Global Clinical Trials
Lambda Therapeutic Research, United Kingdom -
Maren von Fritschen, PHARMD Drug Development and Regulatory Affairs - MSC Course
University of Applied Sciences, Germany -
Ning Xu, MD, MBA Executive Vice President, Head of Global Clinical Operations, Zailab
Zai Lab, China -
Peter Bachmann Retired from Head International Liaison Office and Conferences, Executive Depart
Federal Institute for Drugs and Medical Devices (BfArM), Germany -
Beatriz Vicen Banzo Head of Regulatory Affairs
Bayer Healthcare, Spain -
Truus Janse-de Hoog, PHARMD, MSC Senior former Staff Member of the Medicines Evaluation Board
Netherlands -
Maureen McGahan Planning and Development Department
DIA Europe, Switzerland -
Katrin Rupalla, PHARMD, MBA Senior Vice President
H. Lundbeck A/S, Denmark
